Form 8-K - Current report:
SEC Accession No. 0001104659-25-042955
Filing Date
2025-05-01
Accepted
2025-05-01 06:30:23
Documents
15
Period of Report
2025-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2513742d1_8k.htm   iXBRL 8-K 35799
2 EXHIBIT 99.1 tm2513742d1_ex99-1.htm EX-99.1 370595
6 GRAPHIC tm2513742d1_8kimg001.jpg GRAPHIC 7652
  Complete submission text file 0001104659-25-042955.txt   631961

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA idxx-20250501.xsd EX-101.SCH 3005
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE idxx-20250501_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idxx-20250501_pre.xml EX-101.PRE 22352
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2513742d1_8k_htm.xml XML 3566
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 25899197
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)